Issue 4/2013
Content (8 Articles)
LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?
- Current Opinion
Joost Besseling, Julian van Capelleveen, John J. P. Kastelein, G. Kees Hovingh
Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research
- Leading Article
Cristan Farmer, Audrey Thurm, Paul Grant
Promising New Molecular Targeted Therapies in Head and Neck Cancer
- Leading Article
Kelly Dorsey, Mark Agulnik
Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
- Therapy in Practice
Joe M. Chehade, Margaret Gladysz, Arshag D. Mooradian
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments
- Review Article
Bin-Chi Liao, Chia-Chi Lin, James Chih-Hsin Yang
Brentuximab Vedotin: A Review of Its Use in Patients with Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma Following Previous Treatment Failure
- Adis Drug Evaluation
Karly P. Garnock-Jones